Health Care · Services-General Medical & Surgical Hospitals, NEC · NYSE · CIK 1756655 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $10.73Day −1.83%Mkt cap $1.5BP/E (FY) 11.2×1Y +0.5%Off 52W high −30.7%Vol (1Y) 54.9%
Daily closing price, split-adjusted to the current basis; 2y shown of 507 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest3.2% of sh out |
| Days to cover8.4d |
| 13F net flow (QoQ)+0.47% |
| Top-10 13F concentration91.3% |
| Next report (est.)2026-08-04 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| P/E (FY)11.2× |
| Sales (TTM)$6.43B |
| Earnings (TTM)$134.3M |
| ROE11.2% |
| Net margin2.1% |
| Debt / equity0.85× |
| EPS growth 3Y−13.8% |
| Sales growth 3Y7.2% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+21.5% |
| 1Y+0.5% |
| Since incept. (ann.)−18.0% |
Total return through 2026-07-30 · series begins 2024-07-18. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)54.9% |
| Ann. volatility (3Y)53.1% |
| Sharpe (1Y)0.31 |
| Sharpe (3Y)−0.09 |
| Max drawdown (1Y)−48.5% |
| Max drawdown (3Y)−61.2% |
| Beta (3Y vs SPY)0.66 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| CHAI TRUST CO LLC | 77.2M | $661M | 54.06% | +0.0% |
| Ventas, Inc. | 9.3M | $80M | 6.54% | +0.0% |
| GOLDENTREE ASSET MANAGEMENT LP | 2.3M | $20M | 1.61% | +0.0% |
| AMERIPRISE FINANCIAL INC | 1.8M | $15M | 1.24% | +58.4% |
| BlackRock, Inc. | 1.8M | $15M | 1.23% | +3.1% |
| CastleKnight Management LP | 1.1M | $9M | 0.75% | −7.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.0M | $9M | 0.71% | new |
| AQR CAPITAL MANAGEMENT LLC | 942,353 | $8M | 0.66% | +64.2% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-05 | $0.28 | −3.4% | $1.60B | +7.0% |
| 2025-12-31 | 2026-03-04 | — | — | $1.61B | −0.1% |
| 2025-09-30 | 2025-11-12 | −$0.17 | −189.5% | $1.58B | +8.8% |
| 2025-06-30 | 2025-08-05 | $0.52 | +52.9% | $1.65B | +11.9% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-04 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Reportable 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
